The company revealed that it has been granted as many as 11 patents by the US Patent and Trademark Office (USPTO) for the technology used in its implants. The most popular way of treating OSA is through Positive airway pressure (PAP) but it requires the user wearing a mask that is connected to an air pump by a hose.
Nyxoah’s implant is a tiny device that is surgically inserted at the back of the tongue and which stimulates the tongue to move out of the airway during breathing.
“There are many groundbreaking aspects to our solution. Being able to stimulate the tongue muscle all night using a small disposable battery patch is a major innovation. And our ability to enable minimally invasive implantation in a quick outpatient setting should open the procedure to a significant percentage of the affected population. The fact that 11 patents were allowed less than a year from the date we filed them, is a testament to the uniqueness of our solution”, Nyxoah CEO Adi Mashiach said.